Connection
Kristen Nadeau to Hypolipidemic Agents
This is a "connection" page, showing publications Kristen Nadeau has written about Hypolipidemic Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.311 |
|
|
|
-
Tell S, Nadeau KJ, Eckel RH. Lipid management for cardiovascular risk reduction in type 1 diabetes. Curr Opin Endocrinol Diabetes Obes. 2020 08; 27(4):207-214.
Score: 0.173
-
Nadeau KJ, Ehlers LB, Aguirre LE, Reusch JE, Draznin B. Discordance between intramuscular triglyceride and insulin sensitivity in skeletal muscle of Zucker diabetic rats after treatment with fenofibrate and rosiglitazone. Diabetes Obes Metab. 2007 Sep; 9(5):714-23.
Score: 0.071
-
Maahs DM, Wadwa RP, McFann K, Nadeau K, Williams MR, Eckel RH, Klingensmith GJ. Longitudinal lipid screening and use of lipid-lowering medications in pediatric type 1 diabetes. J Pediatr. 2007 Feb; 150(2):146-50, 150.e1-2.
Score: 0.068